1
/
of
0
Olmesar-AM (Olmesartan + Amlodipine)
Olmesar-AM (Olmesartan + Amlodipine)
Regular price
₱1,035.00 PHP
Regular price
Sale price
₱1,035.00 PHP
Unit price
₱34.50 each
Taxes included.
Quantity
Couldn't load pickup availability
Olmesar-AM (Olmesartan + Amlodipine) is a prescription fixed-dose combination antihypertensive medication designed to provide effective, sustained blood pressure control through dual therapeutic mechanisms. This combination therapy delivers superior efficacy for managing high blood pressure (hypertension) in patients who require multi-drug treatment or have not achieved target blood pressure on single-agent therapy.
Olmesartan functions as an angiotensin II receptor blocker (ARB), blocking angiotensin II to relax blood vessels and reduce aldosterone-mediated fluid retention. Amlodipine acts as a calcium channel blocker (CCB), limiting calcium movement into vascular smooth muscle cells to reduce vasoconstriction and improve peripheral blood flow. Together, these complementary mechanisms work synergistically to lower systemic blood pressure more effectively than either agent used alone.
Olmesar-AM is recommended as a first-line or step-up therapy option for hypertension management, particularly for patients with stage 2 hypertension or those requiring rapid, reliable blood pressure reduction. The combination offers a convenient once-daily dosing schedule that enhances medication adherence and patient compliance. Clinical evidence supports its use in reducing the risk of fatal and nonfatal cardiovascular events, including stroke and myocardial infarction, making it an evidence-based choice for comprehensive cardiovascular risk reduction.
The medication is generally well-tolerated with a predictable side-effect profile. Common effects may include peripheral edema, dizziness, and fatigue, which are typically mild and manageable. Dosing is individualized and initiated at lower strengths such as 5/20 mg once daily, with adjustments made based on therapeutic response and tolerability under physician supervision.
Always take Olmesar-AM exactly as prescribed by your healthcare provider, and maintain regular follow-up appointments to monitor blood pressure control and assess ongoing suitability of the therapy.
Olmesartan functions as an angiotensin II receptor blocker (ARB), blocking angiotensin II to relax blood vessels and reduce aldosterone-mediated fluid retention. Amlodipine acts as a calcium channel blocker (CCB), limiting calcium movement into vascular smooth muscle cells to reduce vasoconstriction and improve peripheral blood flow. Together, these complementary mechanisms work synergistically to lower systemic blood pressure more effectively than either agent used alone.
Olmesar-AM is recommended as a first-line or step-up therapy option for hypertension management, particularly for patients with stage 2 hypertension or those requiring rapid, reliable blood pressure reduction. The combination offers a convenient once-daily dosing schedule that enhances medication adherence and patient compliance. Clinical evidence supports its use in reducing the risk of fatal and nonfatal cardiovascular events, including stroke and myocardial infarction, making it an evidence-based choice for comprehensive cardiovascular risk reduction.
The medication is generally well-tolerated with a predictable side-effect profile. Common effects may include peripheral edema, dizziness, and fatigue, which are typically mild and manageable. Dosing is individualized and initiated at lower strengths such as 5/20 mg once daily, with adjustments made based on therapeutic response and tolerability under physician supervision.
Always take Olmesar-AM exactly as prescribed by your healthcare provider, and maintain regular follow-up appointments to monitor blood pressure control and assess ongoing suitability of the therapy.